Dr. Ana Maria Corregidor, MD

Dr. Corregidor practices at Jacksonville Center for Endoscopy Southside in Jacksonville, Florida.

Dr. Corregidor's NPI, 1306842810, was assigned on June 21, 2005. Dr. Corregidor graduated from Complutense University of Madrid in 1991. Dr. Corregidor holds Florida license ME82898.

Dr. Corregidor's primary practice is Jacksonville Center for Endoscopy Southside, at 4800 Belfort Road, Jacksonville, FL 32256. The practice phone is (904) 265-4801.

Dr. Corregidor's primary practice is Jacksonville Center for Endoscopy Southside in Jacksonville, Florida. Dr. Corregidor is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Borland Groover. Dmand AI also links Dr. Corregidor to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corregidor practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Corregidor's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Corregidor is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Corregidor is licensed in Florida.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Corregidor treats.

CMS data shows 20,097 Medicare services from Dr. Corregidor across 20 procedure codes in 2024, for 577 Medicare patients. Medicare paid $447,261 for them.

CMS counts 577 Medicare patients who saw Dr. Corregidor in 2024. The largest group is 65 to 74, with 313 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Corregidor's median patient age at 62, with 67% women.

In 2024, Dr. Corregidor wrote 602 Medicare Part D claims for 205 patients. 90% of them were for generic drugs. CMS names the drug for 478 of them, across 12 drugs with 11 or more claims each, at $55,403 in total drug cost. In 2023, CMS named 488 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Corregidor for performance year 2024, reported as part of a group. Dr. Corregidor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of colonoscopy by Dr. Corregidor, more than 73% of the clinicians it reports for that procedure.

CMS Open Payments shows 889 general payments to Dr. Corregidor from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Madrigal Pharmaceuticals paid the most, $63,263.

Dr. Corregidor graduated from Complutense University of Madrid in 1991.

Dr. Corregidor is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.